IDEAYA Biosciences, Inc. (IDYA)
33.86
+1.01
(+3.07%)
USD |
NASDAQ |
Oct 19, 15:33
IDEAYA Biosciences Cash from Operations (Annual) : -71.10M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -71.10M |
| December 31, 2024 | -247.58M |
| December 31, 2023 | -115.22M |
| December 31, 2022 | -87.18M |
| December 31, 2021 | -55.78M |
| Date | Value |
|---|---|
| December 31, 2020 | 55.46M |
| December 31, 2019 | -39.31M |
| December 31, 2018 | -27.62M |
| December 31, 2017 | -12.22M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 127.04M |
| Xencor, Inc. | -135.12M |
| BioMarin Pharmaceutical, Inc. | 827.99M |
| MediciNova, Inc. | -9.810M |
| Viking Therapeutics, Inc. | -278.68M |